Issue 54, 2018

Novel hemagglutinin-binding sulfated oligofucosides and their effect on influenza virus infection

Abstract

Among a series of chemically synthesized fucoidan derivatives (1–9), 5 was found for the first time to bind to influenza virus hemagglutinins (HAs) and inhibit hemagglutination activity. In addition, a designed C3-symmetric tripodal ligand 10, synthesized with three sulfated oligofucoside moieties of 5, exhibited much greater hemagglutination inhibition activity than 5. A plaque assay using MDCK cells demonstrated that 10 effectively inhibited influenza virus infection.

Graphical abstract: Novel hemagglutinin-binding sulfated oligofucosides and their effect on influenza virus infection

Supplementary files

Article information

Article type
Communication
Submitted
14 May 2018
Accepted
05 Jun 2018
First published
08 Jun 2018

Chem. Commun., 2018,54, 7467-7470

Novel hemagglutinin-binding sulfated oligofucosides and their effect on influenza virus infection

S. Kosono, A. Kasai, S. Komaba, T. Matsubara, T. Sato, D. Takahashi and K. Toshima, Chem. Commun., 2018, 54, 7467 DOI: 10.1039/C8CC03865A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements